Indeed, in this study, the TTF-1-positive group exhibited a significantly higher proportion of adenocarcinomas and a smaller proportion of non-adenocarcinoma NSCLCs than the TTF-1-negative group. This evidence concerns the gene TTF1 and adenocarcinoma.